Abstracts Published in the Transplantation Journal

All abstract presentations listed in the program have been assigned consecutive program numbers. This number corresponds to the number of the abstract that can be viewed online on the Congress WebApp and in the online supplement of the Transplantation Journal.

The free online version of Transplantation can be accessed here:    Abstracts


Abstract Submission Process

User Profile

Before submitting an abstract, the submitter must create a User Profile. After an abstract has been created, modifications can be made until the submission deadline. There is no limit on the number of abstract submissions from any one individual.

The final deadline to submit the abstract(s) is April 30, 2017. Abstracts will not be able to be submitted online after this date.The submitting author will receive notification of acceptance by May 29, 2017. At the time of the confirmation of acceptance of your abstract, presenters will be requested to register for the congress. Deadline for abstract confirmation of acceptance and presenter registration is June 16, 2017.

Important Dates

April 30, 2017 Abstract submission deadline
May 29, 2017 Communication to submitter on approved / rejected abstracts
June 16, 2017 Deadline for presenter registration
August 2017 Final Program Online

Choosing a Topic

During the submission process, you will be asked to select the primary topic for your abstract. The topic is the general heading under which the abstract will be reviewed and later published in the congress materials, if accepted. The topic which best describes the subject of the abstract should be chosen. ISODP 2017 reserves the right to reassign the primary topic for the abstract for the purposes of programming.

Abstract Structure

All abstracts should be formatted into the following four sections:

  • Introduction: clarifies the motivation for the research presented.
  • Methods: provides sufficient detail for others to reproduce what is studied in the research project.
  • Results: presents and discusses the results.
  • Conclusion: presents the outcome of the work by interpreting the findings and by relating these findings to the motivation stated in the Introduction. Explain the significance of your findings / outcomes and future implications of the results.

Abstract Guidelines

All abstracts must be submitted electronically through the Congress abstract submission website

  • Abstracts will be accepted in English only
  • There is no fee for submitting an abstract
  • There are no limitations on the number of abstracts that an individual can submit. However, one individual can only present 3 abstract as oral presentations during the entire Congress. If you have more than 3 orals accepted, you will be obliged to identify alternate presenters for any abstract above the first three.
  • The abstract text body is limited to 2,500 characters (Approx. 400 words) including spaces. A maximum of two figures/images (in JPG, GIF, or PNG with ideally 600 dpi) can be included. These will not count toward the word limit, nor will the information about authors, institutions and study groups. File size of 2 MB maximum for each figure.
  • Tables: do not insert tables into the body of the abstracts, the system will not recognize the format of the table. Tables will need to be uploaded as image into the body of the abstract.
  • Abstracts accepted for presentation will be published electronically in Transplantation, the official journal of The Transplantation Society. Abstracts not accepted for presentation or if the presenter is not officially registered to the Congress by the June 16th deadline will not be published. Abstracts will also be posted prior to the Congress on the detailed program of the Congress website.
  • Employees of Commercial Entities: ISODP 2017 recognizes that employees of commercial entities are often involved in research and discovery and encourages these employees to submit abstracts to facilitate the flow of new information. Employees of commercial entities should submit abstracts when the content is limited to basic science research (e.g., pre-clinical research, drug discovery) or the processes/methodologies of research, themselves unrelated to a specific disease or compound/drug, and the abstract is not related to clinical applications of the research/discovery or clinical recommendations concerning the business lines or products of their employer.
  • Disclosure: abstract submitter and presenter are required to disclose any conflict of interest.
  • Ensure that all co-authors approve of the abstract submission, publication, and potential presentation. Abstracts cannot be changed or withdrawn after April 21, 2017. Once the abstract has been scored by reviewers, no change in the body of the abstract will be accepted.
  • To be eligible to submit an abstract, you must disclose that the authors/ scientists have not violated any aspect of The Transplantation Society Ethics statements and that this research conforms with the ethical statements noted.

Policies for Abstract Submission

Copyright Policy

Abstracts should not include libelous or defamatory content. Material presented in abstracts should not violate any copyright laws. If figures/graphics/images have been taken from sources not copyrighted by the author, it is the author’s sole responsibility to secure the rights from the copyright holder in writing to reproduce those figures/graphics/images for both worldwide print and web publication. All reproduction costs charged by the copyright holder must be borne by the author.

Resubmission Policy

ISODP 2017 welcomes the submission of abstracts that have been presented previously at regional, national, or international meetings in the two years since the last ISODP 2015 meeting in Korea, given the highly specialized nature of the related topics.

Ethics Compliance

To be eligible to submit an abstract, you must disclose that the authors/ scientists have not violated any aspect of The Transplantation Society Ethics statements and that this research conforms with the ethical statements noted.

Scientific studies and clinical activities should be performed in keeping with the ethical principles delineated in the following policy documents:

Abstract Review and Selection Process

Abstract Review

  • All submitted abstracts will go through a blinded peer-review process carried out by an international review committee.
  • All abstracts will be reviewed (blinded) by at least three international referees, selected by the organizing committee.
  • Abstracts which do not meet the focus of the topic category as requested by the authors will be reassigned to other category.
  • Scores assigned by all reviewers are averaged. The cut-off average score for acceptance is based on available oral and poster presentations. Rejections are further evaluated by the scientific program committee.
  • Poster and oral presentations are viewed as equally important components of the ISODP 2017 Congress.

Format of presentation

You may opt to submit your abstract to be considered for an oral presentation, a poster presentation, or either (at the committee’s discretion).

Notification of Acceptance or Rejection to Corresponding Author

Notification of acceptance or rejection will be sent to the submitting (corresponding) author by May 29, 2017. Please note that only the corresponding author will receive mail concerning the abstract and is responsible for informing all co-authors of the status of the abstract. Authors whose abstracts have been accepted will receive instructions for the presentation of their abstract.

Abstract Submission Topics

  • Bioethics and Legal Aspects
  • Brain Death
  • DBD Programs
  • DCD Programs
  • Donor Management
  • Education, Communication and Promotion
  • Family Care
  • Intensive Care and Donation
  • LD Programs
  • Organ Allocation
  • Organ Preservation
  • Organ Utilization
  • Organization and Public Policies
  • Safety and Vigilance
  • Tissue Donation
  • Transmissible Diseases
  • Others

Rule of Three

Each presenting author may present a maximum of three abstracts as orals at the congress. The number of submissions is however not limited. Should an author have more than three abstracts accepted for presentation, a co-author must be named as presenting author for one or more abstracts.